221 results
6-K
EX-99.1
TAK
Takeda Pharmaceutical Co
9 May 24
Current report (foreign)
6:08am
, indicators on profit, R&D targets. Based on factors including the achievement of company performance goals, a performance linked coefficient which varies … and diverse pipeline. As a leading values-based, R&D-driven biopharmaceutical company headquartered in Japan, we are guided by our commitment
6-K
TAK
Takeda Pharmaceutical Co
9 May 24
Current report (foreign)
6:04am
and diverse pipeline. As a leading values-based, R&D-driven biopharmaceutical company headquartered in Japan, we are guided by our commitment
6-K
TAK
Takeda Pharmaceutical Co
9 May 24
Current report (foreign)
6:03am
and includes initiatives to optimize its workforce—simplifying some division structures—and rigorously prioritize its R&D pipeline, while investing in DD&T … options through our dynamic and diverse pipeline. As a leading values-based, R&D-driven biopharmaceutical company headquartered in Japan, we are guided
6-K
TAK
Takeda Pharmaceutical Co
9 May 24
Current report (foreign)
6:02am
, termination of some of partnered R&D programs coupled with increased R&D expense accruals, and higher other operating expenses. Core Operating Profit increased … impacted by generic entrants for high-margin products and strategic investments in R&D and our data, digital and technology capabilities to ensure our
6-K
TAK
Takeda Pharmaceutical Co
9 May 24
Current report (foreign)
6:01am
(1) Business Performance
(i) Business Overview
Takeda is a global, values-based, R&D-driven biopharmaceutical company with a diverse portfolio … areas: Gastroenterology (“GI”), Rare Diseases, Plasma-Derived Therapies (“PDT”)*1, Oncology, Vaccines*2 and Neuroscience. Our R&D efforts are focused
6-K
EX-99.1
wpc8jes6 3e2
9 May 24
Current report (foreign)
6:01am
6-K
EX-99.1
ooi3tq
19 Apr 24
Current report (foreign)
6:12am
6-K
1q9gvip8
15 Apr 24
Current report (foreign)
6:02am
6-K
igs8h0
27 Mar 24
Current report (foreign)
6:34am
6-K
baozbiqkr5j
9 Feb 24
Current report (foreign)
6:03am
6-K
8aez54h8
2 Feb 24
Current report (foreign)
6:16am
6-K
2fuq2n
1 Feb 24
Current report (foreign)
6:18am
6-K
43bsi616z
1 Feb 24
Current report (foreign)
6:06am
6-K
EX-99.1
id5s0pm 7j5v4nbzf3
1 Feb 24
Current report (foreign)
6:06am
6-K
bonuqj0raf5 oj
16 Jan 24
Current report (foreign)
6:01am
6-K
EX-99.1
it2tpan
14 Dec 23
Current report (foreign)
6:01am
6-K
EX-99.1
enqg3vyd6 9c
30 Nov 23
Current report (foreign)
6:01am
6-K
l074 om57dpoeh4wz
13 Nov 23
Current report (foreign)
6:05am
6-K
d54uuac
30 Oct 23
Current report (foreign)
6:02am
6-K
EX-99.1
vh2ykrhhz
30 Oct 23
Current report (foreign)
6:02am